D. E. Shaw & Co., Inc. Merck & Co., Inc. Put Options Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

Put Options

26 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$111.15 - $128.97 $33,345 - $38,691	-300 Reduced 0.32%	94,300 $10.7 Million
Q2 2024 Aug 14, 2024	SELL	$123.8 - $132.96 $891,360 - $957,312	-7,200 Reduced 7.07%	94,600 $11.7 Million
Q1 2024 May 15, 2024	BUY	$113.24 - $131.95 $4.56 Million - $5.32 Million	40,300 Added 65.53%	101,800 $13.4 Million
Q4 2023 Feb 14, 2024	SELL	$100.18 - $109.02 $13.5 Million - $14.7 Million	-134,900 Reduced 68.69%	61,500 $6.7 Million
Q3 2023 Nov 14, 2023	SELL	$102.95 - $114.33 $14.4 Million - $15.9 Million	-139,500 Reduced 41.53%	196,400 $20.2 Million
Q2 2023 Aug 14, 2023	BUY	$108.61 - $118.38 $14.3 Million - $15.6 Million	131,700 Added 64.5%	335,900 $38.8 Million
Q1 2023 May 15, 2023	SELL	$102.94 - $114.86 $4.53 Million - $5.05 Million	-44,000 Reduced 17.73%	204,200 $21.7 Million
Q4 2022 Feb 14, 2023	SELL	$87.44 - $112.11 $9.92 Million - $12.7 Million	-113,500 Reduced 31.38%	248,200 $27.5 Million
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $23.9 Million - $26.9 Million	282,900 Added 359.01%	361,700 $31.2 Million
Q2 2022 Aug 15, 2022	SELL	$83.49 - $94.64 $35.7 Million - $40.5 Million	-427,500 Reduced 84.44%	78,800 $7.18 Million
Q1 2022 May 16, 2022	SELL	$73.51 - $82.4 $57.7 Million - $64.6 Million	-784,300 Reduced 60.77%	506,300 $41.5 Million
Q4 2021 Feb 14, 2022	BUY	$72.28 - $90.54 $34.9 Million - $43.8 Million	483,500 Added 59.91%	1,290,600 $98.9 Million
Q3 2021 Nov 15, 2021	SELL	$71.68 - $78.83 $8.7 Million - $9.57 Million	-121,400 Reduced 13.07%	807,100 $60.6 Million
Q2 2021 Aug 16, 2021	BUY	$70.31 - $77.77 $7.75 Million - $8.57 Million	110,200 Added 13.47%	928,500 $72.2 Million
Q1 2021 May 17, 2021	BUY	$68.86 - $81.11 $19.7 Million - $23.3 Million	286,700 Added 53.93%	818,300 $63.1 Million
Q4 2020 Feb 16, 2021	BUY	$71.77 - $79.65 $11.4 Million - $12.6 Million	158,600 Added 42.52%	531,600 $43.5 Million
Q3 2020 Nov 16, 2020	SELL	$73.18 - $82.95 $3.73 Million - $4.23 Million	-51,000 Reduced 12.03%	373,000 $30.9 Million
Q2 2020 Aug 14, 2020	BUY	$70.42 - $80.13 $13.2 Million - $15.1 Million	187,900 Added 79.58%	424,000 $32.8 Million
Q1 2020 May 15, 2020	BUY	$63.36 - $87.82 $14.8 Million - $20.5 Million	233,000 Added 7516.13%	236,100 $18.2 Million
Q2 2019 Aug 14, 2019	SELL	$69.84 - $81.59 $5.88 Million - $6.87 Million	-84,200 Reduced 96.45%	3,100 $260,000
Q1 2019 May 15, 2019	SELL	$69.58 - $79.36 $81.7 Million - $93.2 Million	-1,174,600 Reduced 93.08%	87,300 $7.26 Million
Q4 2018 Feb 14, 2019	BUY	$65.24 - $75.71 $34 Million - $39.5 Million	521,900 Added 70.53%	1,261,900 $96.4 Million
Q3 2018 Nov 14, 2018	SELL	$57.69 - $67.84 $19.2 Million - $22.6 Million	-332,700 Reduced 31.02%	740,000 $52.5 Million
Q2 2018 Aug 14, 2018	SELL	$50.83 - $59.72 $9.37 Million - $11 Million	-184,300 Reduced 14.66%	1,072,700 $65.1 Million
Q1 2018 May 15, 2018	BUY	$50.96 - $59.23 $36.8 Million - $42.8 Million	723,100 Added 135.44%	1,257,000 $68.5 Million
Q4 2017 Feb 14, 2018	BUY	$51.62 - $61.64 $27.6 Million - $32.9 Million	533,900	533,900 $30 Million

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

Vanguard Group Inc Valley Forge, PA

250M
Shares

$24.6 Billion
0.52% of portfolio
Black Rock Inc. New York, NY

207M
Shares

$20.4 Billion
0.59% of portfolio
State Street Corp Boston, MA

119M
Shares

$11.7 Billion
0.56% of portfolio
Wellington Management Group LLP Boston, MA

75.8M
Shares

$7.46 Billion
1.55% of portfolio
Geode Capital Management, LLC Boston, MA

59.2M
Shares

$5.82 Billion
0.55% of portfolio

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $249B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account